Panacea Biotec Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the stock exchanges that its trading window will remain closed for all designated persons and their immediate relatives starting July 1, 2025. The window will reopen 48 hours after the company announces its unaudited financial results for the quarter ending June 30, 2025 (Q1 FY2026). This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015. The exact date of the board meeting to approve these quarterly results has not yet been disclosed and will be communicated later.
This is a routine regulatory filing with no direct impact on shareholders. However, it signals that the company's Q1 FY2026 results are likely to be announced in early to mid-July 2025, which is the next key catalyst for the stock.